| pubmed-article:8659177 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8659177 | lifeskim:mentions | umls-concept:C0019159 | lld:lifeskim |
| pubmed-article:8659177 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:8659177 | lifeskim:mentions | umls-concept:C0042212 | lld:lifeskim |
| pubmed-article:8659177 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:8659177 | lifeskim:mentions | umls-concept:C2003864 | lld:lifeskim |
| pubmed-article:8659177 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8659177 | pubmed:dateCreated | 1996-7-29 | lld:pubmed |
| pubmed-article:8659177 | pubmed:abstractText | Clinical trials of inactivated hepatitis A vaccine Hep-A-in-Vac demonstrated its specific safety and moderate reactogenicity, manifesting by short-term fibrillar twitching of musculus deltoideus at the site of injection. After a course of three immunizations 87.5% seronegative vaccines developed a high level of specific antibodies to hepatitis A virus with at least 100 reverse values of titers. In controls antibody titers remained seronegative in 90% cases. These data indicate evident immunologic activity of Hep-A-in-Vac vaccine. | lld:pubmed |
| pubmed-article:8659177 | pubmed:language | rus | lld:pubmed |
| pubmed-article:8659177 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8659177 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8659177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8659177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8659177 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8659177 | pubmed:issn | 0507-4088 | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:KarpovichL... | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:PavlovaL ILI | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:GorbunovM AMA | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:BektimirovT... | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:KalashnikovaT... | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:ShervarliV... | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:ErmolaevaT... | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:LevinaV DVD | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:Ma?daniukA... | lld:pubmed |
| pubmed-article:8659177 | pubmed:author | pubmed-author:BalashevB PBP | lld:pubmed |
| pubmed-article:8659177 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8659177 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:8659177 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8659177 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:8659177 | pubmed:pagination | 219-21 | lld:pubmed |
| pubmed-article:8659177 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8659177 | pubmed:meshHeading | pubmed-meshheading:8659177-... | lld:pubmed |
| pubmed-article:8659177 | pubmed:meshHeading | pubmed-meshheading:8659177-... | lld:pubmed |
| pubmed-article:8659177 | pubmed:meshHeading | pubmed-meshheading:8659177-... | lld:pubmed |
| pubmed-article:8659177 | pubmed:meshHeading | pubmed-meshheading:8659177-... | lld:pubmed |
| pubmed-article:8659177 | pubmed:meshHeading | pubmed-meshheading:8659177-... | lld:pubmed |
| pubmed-article:8659177 | pubmed:articleTitle | [Evaluation of reactivity and immunogenicity of a cultured concentrated inactivated vaccine against hepatitis A "Hep-A-In-Vak"]. | lld:pubmed |
| pubmed-article:8659177 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8659177 | pubmed:publicationType | English Abstract | lld:pubmed |
